Citation

Athe Tsibris, M.D. Evolution of CCR5 antagonist resistance in an HIV-1 subtype C clinical isolate. Journal of Acquired Immune Deficiency Syndromes. 2010 Dec 01; 55(4):420-7. PMID: 20856130; PMCID: PMC3070184.

Citation

Kenneth E. Sherman, M.D., Ph.D., Susan D. Rouster, B.S., S. Stanford, Jason T. Blackard, Ph.D., Norah Shire, M.P.H., Margaret James Koziel, M.D., Marion G. Peters, M.D., Raymond T. Chung, M.D. Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens. Journal of Infectious Diseases. 2010 Mar 01; 201(5):712-9. PMID: 20105080; PMCID: PMC2827649.

Citation

Ronald J. Bosch, Ph.D., Richard B. Pollard, M.D., Alan Landay, Ph.D., Evgenia Aga, M.Sc., Lawrence Fox, M.D., Ph.D., Ronald T. Mitsuyasu, M.D. Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG protocol A5051, a rollover trial of ACTG protocol A328). AIDS Research & Therapy (online journal). 2010 Aug 05; 7(30):30. PMID: 20687947; PMCID: PMC2924251.

Citation

Kevin R. Robertson, Ph.D. Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort. Neurology. 2010 Apr 20; 74(16):1260-6. PMID: 20237308; PMCID: PMC2860482.

Citation

Susan B Brogly, Marc Foca, Jaime G Deville, Mark Mirochnick, Gwendolyn B Scott, Lynne M Mofenson, Jennifer S Read, Rolando M Viani, Sandra K Burchett, Ellen R Cooper, Renee Browning, David E Shapiro. Potential confounding of the association between exposure to nucleoside analogues and mitochondrial dysfunction in HIV-uninfected and indeterminate infants. Journal of Acquired Immune Deficiency Syndromes. 2010 Jan 01; 53(1):154-7. PMID: 20035168; PMCID: PMC3241607.

Citation

Leslie Serchuck, M.D., Paige L. Williams, Ph.D., Sharon Appelbaum Nachman, M.D., Kenneth D. Gadow, Ph.D., Miriam Chernoff, Ph.D., Lynnae Schwartz. Prevalence of pain and association with psychiatric symptom severity in perinatally HIV-infected children as compared to controls living in HIV-affected households. AIDS Care. 2010 May 01; 22(5). PMID: 20401767; PMCID: PMC3156589.

Citation

Brookie M Best, Alice M Stek, Mark Mirochnick, ChengCheng Hu, Hong Li, Sandra K Burchett, Steven S Rossi, Elizabeth Smith, Jennifer S Read, Edmund V Capparelli, International Maternal Pediatric Adolescent AIDS Clinical Trials Group 1026s Study Team. Lopinavir tablet pharmacokinetics with an increased dose during pregnancy. Journal of Acquired Immune Deficiency Syndromes. 2010 Aug 01; 54(4):381-8. PMID: 20632458; PMCID: PMC3265163.

Citation

David W Ouyang, Susan Brogly, Ming Lu, David E Shapiro, Ronald C Hershow, Audrey L French, Robert M Leighty, Bruce Thompson, Ruth E Tuomala. Lack of increased hepatotoxicity in HIV-infected pregnant women receiving nevirapine compared with other antiretrovirals. AIDS. 2010 Jan 02; 24(1):109-14. PMID: 19926957; PMCID: PMC3388940.

Citation

Kunjal Patel, David E Shapiro, Susan B Brogly, Elizabeth G Livingston, Alice M Stek, Arlene D Bardeguez, Ruth E Tuomala. Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy. Journal of Infectious Diseases. 2010 Apr 01; 201(7):1035-44. PMID: 20196654; PMCID: PMC2946359.

Citation

Denise Jacobson, Jane C. Lindsey, Sc.D., Catherine M. Gordon, M.D., M.Sc., John ( Jack ) Moye, Jr., M.D., Dana S. Hardin, M.D., Kathleen Mulligan, Ph.D., Grace M. Aldrovandi, MD. Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045. AIDS. 2010 Mar 13; 24(5):687-96. PMID: 20168204; PMCID: PMC3154736.